top of page
Home: Welcome
Magnetic Cell Delivery:.
A Platform
for Cell Therapy
Our Technology
Magnetic Cell Delivery:
A Platform for Cell Therapies
Regenerative medicine using cell therapies to replace or enhance damaged tissue is often limited by the ability to localize these cells to the target tissue. Once delivered, these cells then need to remain at that site to facilitate integration into the host tissue.
Using a proprietary Magnetic Cell Delivery nanoparticle platform, Emmecell solves the challenges of delivery, retention, and integration of cell therapies by leveraging magnetic nanoparticles to effectively localize and integrate cell therapies to the appropriate target tissue.
Emmecell has a broad IP portfolio and is focusing its initial efforts on ophthalmic indications.
Our mission is to bring innovative regenerative medicine out of the laboratory and into patient care
cGMP Manufacturing
CellMP is a subsidiary of Emmecell that provides integrated research, process development, cGMP manufacturing, and testing services to biotechnology companies and startups. Leveraging deep expertise in cell-based therapies, CellMP supports partners from early development through clinical-stage manufacturing with a focus on quality, scalability, and regulatory compliance.
bottom of page